Company Overview of Innovacell Biotechnologie AG
Innovacell Biotechnologie AG, a biotechnology company, develops personalized cell therapies for treatment of incontinence. It provides ICES13 and ICEF15, cell-based therapy products for treatment of stress urinary incontinence and faecal incontinence, respectively. The company was founded in 2000 and is based in Innsbruck, Austria with laboratory and productions facilities in Innsbruck, Austria.
Life Science Center
Founded in 2000
43 512 - 573680
43 512 - 573680-5
Key Executives for Innovacell Biotechnologie AG
Innovacell Biotechnologie AG Key Developments
Similar Private Companies By Industry
|Bender MedSystems GmbH||Europe|
|Emergentec Biodevelopment GmbH||Europe|
|Activartis Biotech GmbH||Europe|
|Lactosan GmbH & Co. KG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Innovacell Biotechnologie AG, please visit www.innovacell.at. Company data is provided by Capital IQ. Please use this form to report any data issues.